Table 2.
Clinical results at baseline (T0), six (T1) and twelve (T2) months
| Grupo | T0 | T1 | T2 | T0-T1 | T0-T2 | T1-T2 | ||
|---|---|---|---|---|---|---|---|---|
| (baseline) (mean ± SD) |
(6 months) (mean ± SD) |
(12 months) (mean ± SD) |
P intragroup | P intragroup | P intragroup | |||
| RECdepth (mm) |
Test (CMX) n = 20 |
3.69 ± 1.03 | 1.48 ± 0.73 | 1.55 ± 0.77 | < 0.001 | < 0.001 | 0.448 | |
|
Control (CTG) n = 20 |
3.68 ± 0.66 | 1.18 ± 0.88 | 1.11 ± 0.78 | 0.905 | ||||
| P (intergroup) | 0.968 | 0.314 | 0.149 | - | - | - | ||
| RECwidth (mm) |
Test (CMX) n = 20 |
4.15 ± 0.74 | 2.83 ± 1.02 | 2.9 ± 0.94 | < 0.001 | < 0.001 | 0.866 | |
|
Control (CTG) n = 20 |
3.91 ± 0.69 | 2.38 ± 1.56 | 2.48 ± 1.58 | 0.767 | ||||
| P (intergroup) | 0.289 | 0.478 | 0.583 | - | - | - | ||
|
KTW (mm) |
Test (CMX) n = 20 |
1.79 ± 1.25 | 2.36 ± 2.47 | 1.96 ± 1.09 | 0.307 | 0.443 | 0.623 | |
|
Control (CTG) n = 20 |
1.78 ± 1.11 | 2.47 ± 1.3 | 2.43 ± 1.17 | 0.004 | 0.01 | 0.752 | ||
| P (intergroup) | 0.968 | 0.301 | 0.242 | - | - | |||
|
CAL (mm) |
Test (CMX) n = 20 |
4.88 ± 1.12 | 2.53 ± 0.78 | 2.64 ± 0.79 | < 0.001 | < 0.001 | 0.14 | |
|
Control (CTG) n = 20 |
4.95 ± 0.76 | 2.35 ± 0.96 | 2.28 ± 0.87 | 0.284 | ||||
| P (intergroup) | 0.565 | 0.738 | 0.265 | - | - | - | ||
REC depth (Recession depth); REC width (Recession width); KTW (keratinized tissue width); CAL (Clinical attachment level); SD (standard deviation); mm (millimeters); CMX (xenogeneic collagen matrix); CTG (connective tissue graft)